Alterola Biotech (ABTI) Price & Analysis

10 Followers

ABTI Stock Chart & Stats

$0.20

>-$0.01(-96.08%)

At close: Jul 14 4:00 PM EDT

$0.20

>-$0.01(-96.08%)

Day’s Range― - ―

52-Week Range$0.20 - $0.20

Previous CloseN/A

Volume5.00K

Average Volume (3M)0.00

Market Cap

$291.90K

Enterprise Value$8.85M

Total Cash (Recent Filing)$9.10K

Total Debt (Recent Filing)$1.55M

Price to Earnings (P/E)―

Beta-22.38

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding1,459,502,100

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio0.30

Price to Book (P/B)3.49

Price to Sales (P/S)0.00

P/FCF Ratio-29.87

Enterprise Value/Market Cap30.32

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/Ebitda-7.95

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

ABTI FAQ

What was Alterola Biotech’s price range in the past 12 months?

Alterola Biotech lowest stock price was $0.20 and its highest was $0.20 in the past 12 months.

What is Alterola Biotech’s market cap?

Alterola Biotech’s market cap is $291.90K.

When is Alterola Biotech’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Alterola Biotech’s earnings last quarter?

Currently, no data Available

Is Alterola Biotech overvalued?

According to Wall Street analysts Alterola Biotech’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Alterola Biotech pay dividends?

Alterola Biotech does not currently pay dividends.

What is Alterola Biotech’s EPS estimate?

Alterola Biotech’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Alterola Biotech have?

Alterola Biotech has 1,459,502,100 shares outstanding.

What happened to Alterola Biotech’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Alterola Biotech?

Currently, no hedge funds are holding shares in ABTI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Alterola Biotech

Alterola Biotech, Inc. is a pharmaceutical company dedicated to the research and development of cannabinoid and cannabinoid-like molecules. The firm primarily focuses on pioneering regulated pharmaceutical products for human and animal health, as well as regulated food items. Key activities also include the production of active pharmaceutical ingredients (APIs) and food-grade components. Furthermore, the company emphasizes drug formulation and advanced delivery systems to improve bioavailability, solubility, and overall stability. It operates out of Birkenhead, United Kingdom.